Interestingly, the tumor cells that survived in the mice had a lower expression of CD1c compared to remaining cells in the control groups, supporting the CD1c-dependent mechanism of tumor recognition and the strong anti-leukemia effect of this TCR, while also suggesting a possible mechanism of immune escape relying on the loss/reduction of the target of the immune response. The gene discussed is CD1C; the disease is leukemia.